ICD-10-CM Billable Code

C91.A1

Mature B-cell leukemia Burkitt-type, in remission

Clinical Classification Guidelines

Medical Intelligence & Overview

Mature B-cell leukemia Burkitt-type is a rare form of blood cancer characterized by the rapid growth of malignant B-cells. This type of leukemia is closely related to Burkitt lymphoma, a highly aggressive form of non-Hodgkin lymphoma. When diagnosed as 'in remission,' it indicates that treatment has effectively reduced or eliminated signs of cancer, and the patient currently shows no evidence of active disease. This article provides a patient-friendly overview of this condition, its causes, symptoms, diagnostic procedures, and typical treatment approaches.

Causes & Symptoms

Clinical Causes: Genetic mutations leading to abnormal B-cell growth Infections, particularly with Epstein-Barr virus (EBV) Immunodeficiency conditions, such as HIV/AIDS Certain genetic syndromes or familial predispositions

Key Symptoms: Rapid swelling of lymph nodes in the neck, abdomen, or other areas Fever and night sweats Unexplained weight loss Fatigue and weakness Abdominal pain or swelling Digestive disturbances, such as nausea or vomiting Persistent sore throat or cough

Diagnostic & Treatment

Diagnosis Path: Blood tests to assess abnormal blood cell counts Lymph node or bone marrow biopsy to identify malignant cells Imaging studies such as CT scans to evaluate the extent of disease spread Molecular and genetic testing to detect specific mutations associated with Burkitt-type leukemia

Treatment Protocols: Aggressive chemotherapy regimens tailored to Burkitt leukemia Targeted therapies focusing on specific molecular abnormalities Supportive care, including transfusions and nutritional support Monitoring for potential relapse through regular follow-up examinations

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C91.A1 a billable ICD-10 code?
Yes, C91.A1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C91.A1?
Clinical documentation must specify the nature of Mature B-cell leukemia Burkitt-type, in remission and any associated comorbidities for accurate reporting.

Cite this Clinical Reference